Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07284875
What this trial is testing

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Who this might be right for
ObesityOverweight
Kailera 2,340
Not applicableStudy completedNCT01727583
What this trial is testing

Boosting the Secretion of GLP-2 and GLP-1 Intestinal Hormones by Nutrients

Who this might be right for
Healthy
Société des Produits Nestlé (SPN) 18
Large-scale testing (Phase 3)Study completedNCT02787551
What this trial is testing

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 514
Early research (Phase 1)Not Yet RecruitingNCT07793929
What this trial is testing

Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

Who this might be right for
End Stage Renal DiseaseRenal ImpairmentObesity+1 more
Kailera 32
Not applicableStudy completedNCT05875636
What this trial is testing

GLP-1 Receptor Agonist Use and Incidence of Retained Gastric Food on Endoscopy

Who this might be right for
Gastric Content Aspiration
Medical University of South Carolina 260
Testing effectiveness (Phase 2)Study completedNCT02908087
What this trial is testing

Incretin-based Therapy in Early Diagnosed Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
University of Oulu 13
Not applicableActive Not RecruitingNCT07422987
What this trial is testing

GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women

Who this might be right for
Body CompositionMuscle FunctionGLP-1+1 more
University of Kansas Medical Center 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT07553299
What this trial is testing

Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Who this might be right for
ObesityOverweightWeight Maintenance
Verdiva Bio Dev Limited 120
Post-approval studies (Phase 4)Study completedNCT02952963
What this trial is testing

Effect of Bile Acids and Bile Acid Sequstrants on GLP-1 Secretion After Roux-en-Y Gastric Bypass

Who this might be right for
Severe Obesity
Hvidovre University Hospital 8
Not applicableStudy completedNCT07362563
What this trial is testing

Effect of Prebiotic Sodas on Postprandial Levels of GLP-1, PYY, Transit Time and Satiety Levels: A Pilot Study

Who this might be right for
Satiety in Healthy Volunteers
Olipop, PBC 15
Early research (Phase 1)Study completedNCT05882032
What this trial is testing

LY3502970 in Participants With Impaired and Normal Liver Function

Who this might be right for
HealthyHepatic Insufficiency
Eli Lilly and Company 29
Not applicableStudy completedNCT03993132
What this trial is testing

A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular Outcomes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 26,774
Not applicableEnrolling By InvitationNCT07640139
What this trial is testing

Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes

Who this might be right for
Obesity
Indiana University 125,000
Not applicableLooking for participantsNCT06278285
What this trial is testing

Effect of Agonist GLP1 on Adipose Tissue in Patients Undergoing Bariatric Surgery

Who this might be right for
Obesity
Centre Hospitalier Universitaire de Nice 40
Not applicableStudy completedNCT06355219
What this trial is testing

Macrovascular and Microvascular Morbidity and Mortality After Metabolic Surgery Versus Medicines

Who this might be right for
Type 2 Diabetes MellitusObesityMicrovascular Disease+6 more
Ali Aminian 3,932
Testing effectiveness (Phase 2)Ended earlyNCT00835328
What this trial is testing

Effect of Exendin (9-39) on Glucose Requirements to Maintain Euglycemia

Who this might be right for
Congenital Hyperinsulinism
Diva De Leon 14
Early research (Phase 1)Ended earlyNCT00637338
What this trial is testing

Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 42
Early research (Phase 1)Study completedNCT01880827
What this trial is testing

Splanchnic Blood Redistribution After Incretin Hormone Infusion and Obesity Surgery

Who this might be right for
Type 2 DiabetesObesity
Turku University Hospital 36
Not applicableStudy completedNCT03701503
What this trial is testing

The Comparison of PYY, Ghrelin, GLP1, Glucose Level, Level of Satiety, and Ad Libitum Intake in Obese and Non-Obese Patients After Breakfast With Balanced Macronutrient Composition

Who this might be right for
PYYGhrelinAppetite+5 more
Universitas Indonesia 40
Not applicableStudy completedNCT02180620
What this trial is testing

Pre-dinner vs. Post-dinner Exercise on Glycemic Control

Who this might be right for
Type 2 Diabetes
University of Missouri-Columbia 13
Next Page